Close
Isomorphic Labs has successfully raised $600 million in its first external funding round, aimed at enhancing its AI-driven drug design capabilities. This funding, led by Thrive Capital with participation from Google Ventures, will support the company's research and development efforts. The investment is a significant step towards advancing Isomorphic Labs' mission to leverage AI in solving various diseases.
The company, a subsidiary of Alphabet, plans to utilize the funds to expand its team and accelerate the development of its next-generation AI drug design engine. CEO Demis Hassabis emphasized the importance of this funding in advancing their clinical programs. Isomorphic Labs is known for its AI platform AlphaFold, which plays a crucial role in drug discovery by predicting protein structures.
• Isomorphic Labs raised $600 million for AI drug design advancements.
• Funding will enhance AI research and clinical development programs.
AI drug design involves using artificial intelligence to create and optimize new pharmaceuticals.
Protein structure prediction is a method used to determine the 3D structure of proteins, essential for drug discovery.
Isomorphic Labs focuses on AI-driven drug design and has developed the AlphaFold platform for protein structure prediction.
Alphabet is the parent company of Isomorphic Labs, supporting its AI initiatives and funding efforts.
The Wall Street Journal 2month
Isomorphic Labs, the AI drug discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600
How to level up your teaching with AI. Discover how to use clones and GPTs in your classroom—personalized AI teaching is the future.
Trump's Third Term? AI already knows how this can be done. A study shows how OpenAI, Grok, DeepSeek & Google outline ways to dismantle U.S. democracy.
Sam Altman today revealed that OpenAI will release an open weight artificial intelligence model in the coming months. "We are excited to release a powerful new open-weight language model with reasoning in the coming months," Altman wrote on X.
Log in
Sign Up
AI Tools - Popular
AI Tools - Categories
GPTs - Categories
AI for Jobs
Key AI Highlights in this Article
Key AI Terms Mentioned in this Article
Companies Mentioned in this Article
